ClinicalTrials.Veeva

Menu

Blood Pressure Measurement in Dialysed Patients (DIALBP)

P

PD Dr. Grégoire Wuerzner

Status

Completed

Conditions

End Stage Renal Disease

Study type

Observational

Funder types

Other

Identifiers

NCT03318653
2017-00352

Details and patient eligibility

About

The objective of the current study is to evaluate the compliance to blood pressure measurements' recommendations in dialysis centers.

The idea is to address a questionnaire to physicians, head nurses and patients in order to probe the way to measure blood pressure. The objective is to face the theoretical guideline with what is effectively done.

Full description

In dialysis center, blood pressure is measured as well as a vital sign than as a predictor of cardiovascular event. Accurate measurement of blood pressure is critical for making appropriate clinical decisions. Guidelines have been issued on standard blood pressure measurement procedure for the detection of hypertension and the follow-up of patients with hypertension. In hospital adherence to guidelines is low (Manzoli, Simonetti et al. 2012). Whether these guidelines are followed in dialysis patients is not known. Thus it would be of great interest to investigate the BP measurement procedures that are effectively applied in dialysis centers.

This project is an international survey across 10 dialysis centers. The current study is conducted on 10 physicians, 10 head nurses and 100 to 200 patients in Switzerland, in Europe and in the Mediterranean basin.

The adherence to BP measurement guidelines will be assessed thanks to two questionnaires of 20 items; one addressed to the patients and the other to the medical staff (clinicians and head nurses).

The project is scheduled to last a total of 4 months. Two months are dedicated to the presentation of the project, the recruitment as well as to the participation of the volunteers, and two months to the analysis.

The research project is carried out in accordance to the research plan and with principles enunciated in the current version of the Declaration of Helsinki (DoH), the Essentials of Good Epidemiological Practice issued by Public Health Schweiz (EGEP), the Swiss Law and Swiss regulatory authority's requirements as applicable.

Enrollment

192 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Dialysed patients (hemodialysis or peritoneal dialysis)

Exclusion criteria

Trial design

192 participants in 2 patient groups

HD - Hemodialysis
Description:
Patients with end stage renal disease treated with hemodialysis
PD - Peritoneal dialysis
Description:
Patients with end stage renal disease treated with peritoneal dialysis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems